UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002716 |
|---|---|
| Receipt number | R000003311 |
| Scientific Title | A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation |
| Date of disclosure of the study information | 2009/11/06 |
| Last modified on | 2014/11/05 10:39:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/11/05 18:46:43 | ||
| 2 | Update | 2010/05/06 14:20:15 | Recruitment status |
|
| 3 | Update | 2012/05/06 15:42:56 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2013/07/22 14:31:28 | Email1 |
|
| 5 | Update | 2014/11/05 10:38:55 | Email |
|
| 6 | Update | 2014/11/05 10:39:28 | Recruitment status |
